In studies on the effect of IL-18 on the anti-CD20 mAb-mediated regression of non-Hodgkin lymphoma, it was demonstrated that IL-18 synergized with the mAb in the lymphoma regression [75]. This evidence concerns the gene IL18 and lymphoma.